Clik here to view.
Genuv Announces Preclinical Data to be Released at Two Medical Conferences in...
SEOUL, South Korea Genuv Inc., a clinical-stage biotechnology company focused on innovative drug discovery for degenerative central nervous system diseases and advanced immuno-oncology therapeutics,...
View ArticleClik here to view.
Embleema and CDISC Partner to Develop Standards for Cell and Gene Therapy...
METUCHEN, N.J. & AUSTIN, Texas Embleema Inc. and CDISC have announced a collaboration to develop new standards for experimental assays and bioinformatics protocols to facilitate monitoring the...
View ArticleClik here to view.
B dot Medical: Successful Proof of Concept for Ultra-compact Proton Therapy...
TOKYO B dot Medical Inc. and Research Center for Nuclear Physics, Osaka University (RCNP) have conducted a Proof of Concept (POC) of the ultra-compact proton therapy system under development and...
View ArticleClik here to view.
Genexine Appoints Industry Veteran Neil Warma as Chief Executive Officer to...
SEOUL, South Korea Genexine (KOSDAQ: 095700) a publicly traded, clinical stage biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of unmet...
View ArticleClik here to view.
InnoCare Announces Approval to Conduct a Phase II Clinical Trial of...
BEIJING InnoCare Pharma (HKEX: 09969) announced today that it has received approval to conduct a single-arm, open-label, multicenter phase II clinical trial evaluating the safety and efficacy of...
View ArticleClik here to view.
BTIG to Host Inaugural China Biotech Day on Wednesday, June 1, 2022
NEW YORK BTIG announced today that it will hold an inaugural China Biotech Day, on Wednesday, June 1, 2022. This virtual event will include thematic panel discussions, fireside chats and one-on-one...
View ArticleClik here to view.
BeiGene Clinical Data Presentations at 2022 ASCO Annual Meeting Demonstrate...
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and...
View ArticleClik here to view.
MEI Pharma and Kyowa Kirin Announce Acceptance of Abstract for Presentation...
SAN DIEGO & TOKYO MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global...
View ArticleClik here to view.
Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing...
CAMBRIDGE, Mass. & OSAKA, Japan & BOTHELL, Wash. Takeda Pharmaceutical Company Limited (TSE:4502) and Seagen Inc., (NASDAQ:SGEN) today announced that overall survival (OS) data from the...
View ArticleClik here to view.
Lumenis OptiLight荣获2022年MedTech Breakthrough奖：眼科最佳新技术解决方案
以色列约克尼穆 (美国商业资讯)–领先的能量型美容和眼科医疗设备公司Lumenis Be.今天宣布，OptiLight荣获竞争激烈的MedTech...
View ArticleClik here to view.
卡妥索单抗治疗晚期胃癌伴腹膜转移临床研究成果入选2022ASCO年会
中国广州 (美国商业资讯)–凌腾医药，一家专注于T细胞衔接抗体开发的临床阶段生物制药公司，今日宣布，美国临床肿瘤学会（American Society of Clinical Oncology, ASCO）已接收卡妥索单抗治疗晚期胃癌伴腹膜转移的Ⅲ期临床试验第一阶段研究成果作为摘要发布。 摘要编号：e16102 摘要标题：Global multi-center phase I trial of...
View ArticleClik here to view.
LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with...
GUANGZHOU, China LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that...
View ArticleClik here to view.
ルミナスのOptiLightが2022年メドテック・ブレークスルー賞の「最優秀眼科用新技術ソリューション」部門を受賞
イスラエル・ヨクネアムイリト （ビジネスワイヤ） —...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Pemetrexed for Injection...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today...
View ArticleClik here to view.
武田和Seagen呈报的ADCETRIS®联合用药数据显示，晚期霍奇金淋巴瘤患者的总生存(OS)改善有统计学意义
马萨诸塞州剑桥和日本大阪和华盛顿州博瑟尔 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502)和Seagen Inc., (NASDAQ:SGEN)今天宣布，ADCETRIS® (brentuximab...
View ArticleClik here to view.
Takeda Presents Latest Research from Oncology Portfolio and Pipeline at ASCO...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it will present data at two upcoming scientific congresses this spring:...
View ArticleClik here to view.
武田薬品とシーゲンが進行期ホジキンリンパ腫の患者で全生存期間（OS）の統計的に有意な改善を示すアドセトリス併用療法のデータを発表へ
米マサチューセッツ州ケンブリッジ & 大阪 & 米ワシントン州ボセル （ビジネスワイヤ） —...
View ArticleClik here to view.
武田在ASCO和EHA上展示肿瘤学产品组合和研发产品线的最新研究成果
马萨诸塞州坎布里奇和日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited,...
View ArticleClik here to view.
武田薬品がASCOおよびEHAでオンコロジー分野のポートフォリオとパイプラインに関する最新研究の成果を発表
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View ArticleClik here to view.
CANbridge Pharmaceuticals to Present at the Jefferies Global Healthcare...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals Inc. (HKEX:1228), a China-based global biopharmaceutical company committed to the research, development and commercialization of...
View Article